Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A4 | Q9H015 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | ALPG | P10696 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9986385 | 1.00 | SLC22A4 (1.00) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL9985141 | 1.00 | SLC22A4 (1.00) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL175156 | 0.86 | SLC22A4 (0.76) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL12039657 | 0.86 | SLC22A4 (0.76) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL745229 | 0.86 | SLC22A4 (0.76) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL20925250 | 0.84 | SLC22A4 (0.72) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL20925187 | 0.82 | SLC22A4 (0.70) | SLC22A4POLBGAAKDM3BKMT2A | |
| SCHEMBL2217967 | 0.82 | SLC22A4 (0.69) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL28099455 | 0.80 | SLC22A4 (0.64) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL9604220 | 0.71 | SLC22A4 (0.55) | SLC22A4POLBGAAKDM3BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4257112-B1 | SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 | COLGATE PALMOLIVE CO (US) | 2026-03-04 | — | — | EP | claimed |
| EP-3969013-B1 | SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS | TOPIX PHARMACEUTICALS INC (US) | 2026-01-07 | — | — | EP | claimed |
| EP-3162357-B1 | COSMETIC PRODUCT WITH LIPOSOMAL GROWTH FACTORS | DERMOPARTNERS S L (ES) | 2025-12-03 | — | — | EP | claimed |
| EP-4089178-B1 | METHOD FOR PRODUCING NOVEL MICROORGANISMS AND ERGOTHIONEINE | KUREHA CORP (JP) | 2025-05-28 | — | — | EP | claimed |
| EP-4520819-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | claimed |
| EP-3965657-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| EP-3466419-B1 | USE OF TRIMETHOXYBENZYL ACETYLSINAPATE, ADVANTAGEOUSLY IN COMBINATION WITH AT LEAST ONE SUNSCREEN, FOR PROTECTING THE SKIN | THOREL JEAN NOEL (FR) | 2024-05-08 | — | — | EP | claimed |
| CN-117883293-A | Prunella spike seed full-ingredient nanoemulsion and preparation method and application thereof | 江西鑫康健科技发展有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117159438-A | Anti-aging skin-tendering compound and preparation method and application thereof | 广州亮妆化妆品有限公司 | 2023-12-05 | — | — | CN | claimed |
| EP-3751001-B9 | ERGOTHIONEINE PRODUCTION METHOD | NAGASE & CO LTD (JP) | 2023-10-04 | — | — | EP | claimed |
| CN-115501127-B | Anti-inflammatory and allergy-relieving composition and daily chemical product | 梅晔生物医药股份有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116327674-A | Anti-wrinkle compact micro-nano essence emulsion and preparation method thereof | 山东安然纳米实业发展有限公司 | 2023-06-27 | — | — | CN | claimed |
| EP-3751001-B1 | ERGOTHIONEINE PRODUCTION METHOD | NAGASE & CO LTD (JP) | 2023-06-07 | — | — | EP | claimed |
| CN-115998639-A | Transparent liquid for skin care and preparation method thereof | 重庆智合生物医药有限公司 | 2023-04-25 | — | — | CN | claimed |
| EP-3248003-B1 | METHOD FOR DETERMINING THE DISTINCTIVE NUTRITIONAL REQUIREMENTS OF A PATIENT | NESTLE SA (CH) | 2023-04-19 | — | — | EP | claimed |
| CN-115575553-A | Application of serum metabolic marker as EGFR mutation detection and detection system | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2023-01-06 | — | — | CN | claimed |
| EP-4031095-A1 | SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT THEREOF) AND A PLANT STEM CELL EXTRACT | PM-International AG (LU) | 2022-07-27 | — | — | EP | claimed |
| CN-113189214-B | Large yellow croaker proliferation and releasing molecular marker and screening method thereof | 宁波大学 | 2022-06-21 | — | — | CN | claimed |
| CN-110478264-A | A kind of cosmetic or skin composition with delay skin aging effect | SHANGHAI COACH TECH CO LTD | 2019-11-22 | — | — | CN | claimed |
| EP-4460300-A4 | USE OF ERGOTHIONEINE FOR ENHANCING GLUTATHIONE LEVEL | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2025-12-31 | — | — | EP | disclosed |
| CN-121102227-A | Ergothioneine compound composition and preparation method thereof | 四川科伦药物研究院有限公司 | 2025-12-12 | — | — | CN | disclosed |
| EP-4469045-A4 | USE OF ERGOTHIONEINE FOR EXTENDING LIFESPAN OR IMPROVING HEALTHSPAN | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2025-11-26 | — | — | EP | disclosed |
| EP-4616198-A1 | A METHOD OF EARLY PREDICTION OF RISK OF PRE-TERM PRE-ECLAMPSIA IN SPECIFIC POPULATION COHORTS | Metabolomic Diagnostics Limited (IE) | 2025-09-17 | — | — | EP | disclosed |
| EP-4303309-A4 | ERGOTHIONEINE PRODUCTION METHOD | NAGASE & CO LTD (JP) | 2025-07-16 | — | — | EP | disclosed |
| EP-4089178-B1 | METHOD FOR PRODUCING NOVEL MICROORGANISMS AND ERGOTHIONEINE | KUREHA CORP (JP) | 2025-05-28 | — | — | EP | disclosed |
| CN-119732881-B | Anti-aging composition for deeply repairing sensitive muscles, application and anti-aging cosmetic | 广州无添加主义化妆品有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20250134866-A1 | COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOME DYSFUNCTION IN THE SKIN OR MOUTH | Trampota Jan (US) | 2025-05-01 | — | — | US | disclosed |
| CN-119859123-A | New crystal form of ergothioneine and preparation method thereof | 天津大学 | 2025-04-22 | — | — | CN | disclosed |
| CN-119732881-A | Anti-aging composition for deeply repairing sensitive muscles, application and anti-aging cosmetic | 广州无添加主义化妆品有限公司 | 2025-04-01 | — | — | CN | disclosed |
| EP-4520819-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | disclosed |
| EP-4520819-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | disclosed |
| CN-116327674-B | Anti-wrinkle compact micro-nano essence emulsion and preparation method thereof | 山东安然纳米实业发展有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-116327674-B | Anti-wrinkle compact micro-nano essence emulsion and preparation method thereof | 山东安然纳米实业发展有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119112749-A | Anti-aging repairing cosmetic composition, and preparation method and application thereof | 马应龙大健康有限公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-4469045-A1 | USE OF ERGOTHIONEINE FOR EXTENDING LIFESPAN OR IMPROVING HEALTHSPAN | Nanjing Nutrabuilding Bio-Tech Co., Ltd. (CN) | 2024-12-04 | — | — | EP | disclosed |
| CN-119033638-A | Anti-aging composition and application thereof, cosmetics and skin care product | 水羊化妆品制造有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-114269722-B | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2024-11-22 | — | — | CN | disclosed |
| EP-4460300-A1 | USE OF ERGOTHIONEINE FOR ENHANCING GLUTATHIONE LEVEL | Nanjing Nutrabuilding Bio-Tech Co., Ltd. (CN) | 2024-11-13 | — | — | EP | disclosed |
| WO-2024193158-A1 | SULFOXIDE SYNTHASE MUTANT AND USE THEREOF IN ERGOTHIONEINE PRODUCTION | 北京华熙荣熙生物技术研究有限公司 | 2024-09-26 | — | — | WO | disclosed |
| CN-118685887-A | Antibacterial and deodorant composite fiber inner core and preparation method thereof | 宁波博洋家纺集团有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118615193-A | Cosmetic emulsion with multiple effects and preparation method thereof | 乐普药业科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118325745-B | Singular yeast and method for preparing ergothioneine by using singular yeast | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2024-08-20 | — | — | CN | disclosed |
| CN-115400065-B | Skin care product composition with multiple effects of moisturizing, anti-wrinkle, anti-aging, relieving and repairing and application thereof | 珠海市柏瑞医药科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118370752-A | Combination of natural amino acids and aminocycloalkanoic acids and method of treating skin disorders | 北京济亦生物医药有限公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118325745-A | Singular yeast and method for preparing ergothioneine by using singular yeast | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2024-07-12 | — | — | CN | disclosed |
| CN-118121726-A | Method for evaluating anti-aging effect of skin care product containing ginseng tissue culture | 山东安然纳米实业发展有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118058997-A | Use, promoter and care product for promoting transdermal absorption of ergothioneine by sugar | 深圳市护家科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118048155-A | Titanium nitride etching liquid, preparation method, application and cleaning method thereof | 浙江奥首材料科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| WO-2024099769-A1 | A METHOD OF EARLY PREDICTION OF RISK OF PRE-TERM PRE-ECLAMPSIA IN SPECIFIC POPULATION COHORTS | Metabolomic Diagnostics Limited (IE) | 2024-05-16 | — | — | WO | disclosed |
| CN-118001264-A | Application of spermidine, expression activity enhancer, ergothioneine and spermidine composition and application thereof | 中科赛立复线粒体医学(深圳)有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117924184-A | Method for separating and purifying ergothioneine from fermentation liquor | 音芙医药科技(上海)有限公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-4245304-A4 | USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE | Bloomage Biotechnology Corporation Limited (CN) | 2024-04-24 | — | — | EP | disclosed |
| CN-117886757-A | Ergothioneine single crystal and preparation method thereof | 上海健力达生物科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117883293-A | Prunella spike seed full-ingredient nanoemulsion and preparation method and application thereof | 江西鑫康健科技发展有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11957737-B2 | Methods of treating microbial infection and inflammation | Colorado Seminary, Owner and Operator of University of Denver (US) | 2024-04-16 | — | — | US | disclosed |
| CN-117800919-A | Application of novel water-infiltrated reversed-phase resin microsphere in separation and purification of ergothioneine or intermediate thereof | 微纯生物科技(广州)有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-4089178-A4 | METHOD FOR PRODUCING NOVEL MICROORGANISMS AND ERGOTHIONEINE | Kureha Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-4303309-A1 | ERGOTHIONEINE PRODUCTION METHOD | Nagase & Co., Ltd. (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-20230406896-A1 | COMPOSITIONS HAVING MULTIPLE RECOMBINANT HUMAN GROWTH FACTORS INCLUDED THEREIN FOR REDUCING SIGNS OF AGING | SKINGENUITY, LLC | 2023-12-21 | — | — | US | disclosed |
| EP-4291182-A1 | MICROBIAL ERGOTHIONEINE BIOSYNTHESIS | Conagen Inc. (US) | 2023-12-20 | — | — | EP | disclosed |
| EP-4052704-A4 | COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR SALT THEREOF | Suntory Holdings Limited (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-2775839-B1 | METHODS FOR ASSESSING REPELLANT QUALITY OF ORGANIC MATERIALS AND METHODS AND COMPOSITIONS FOR REPELLING ARTHROPODS | UNIV CALIFORNIA (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20230296570-A1 | METHOD OF PROCESSING A BIOLOGICAL SAMPLE | Metabolomic Diagnostics Limited (IE) | 2023-09-21 | — | — | US | disclosed |
| EP-4245304-A1 | USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE | Bloomage Biotechnology Corporation Limited (CN) | 2023-09-20 | — | — | EP | disclosed |
| EP-4239331-A1 | A METHOD OF PROCESSING A BIOLOGICAL SAMPLE | Metabolomic Diagnostics Limited (IE) | 2023-09-06 | — | — | EP | disclosed |
| CN-116617100-A | Composition for promoting melanocortin receptor 2 expression and application thereof | 华熙生物科技股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-115501127-B | Anti-inflammatory and allergy-relieving composition and daily chemical product | 梅晔生物医药股份有限公司 | 2023-08-18 | — | — | CN | disclosed |
| WO-2023150241-A1 | COMMENSAL SIGNALLING COMPOUNDS FOR TREATING OR PREVENTING MICROBIOME DYSFUNCTION IN THE SKIN OR MOUTH | Trampota Jan (US) | 2023-08-10 | — | — | WO | disclosed |
| US-11698361-B1 | Method of processing a biological sample | Metabolomic Diagnostics Limited (IE) | 2023-07-11 | — | — | US | disclosed |
| CN-116327674-A | Anti-wrinkle compact micro-nano essence emulsion and preparation method thereof | 山东安然纳米实业发展有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-115998639-A | Transparent liquid for skin care and preparation method thereof | 重庆智合生物医药有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115700090-A | Edible fungus extract composition for improving sleep and application thereof | 浙江百山祖生物科技有限公司 | 2023-02-07 | — | — | CN | disclosed |
| EP-4120996-A1 | SKIN CARE COMPOSITIONS COMPRISING 8 OR MORE RECOMBINANT HUMAN GROWTH FACTORS AND USE THEREOF FOR REDUCING SINGS OF AGING | Skingen International Inc. (CA) | 2023-01-25 | — | — | EP | disclosed |
| CN-115575553-A | Application of serum metabolic marker as EGFR mutation detection and detection system | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2023-01-06 | — | — | CN | disclosed |
| US-20220362349-A1 | METHODS OF TREATING MICROBIAL INFECTION AND INFLAMMATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2022-11-17 | — | — | US | disclosed |
| EP-4089178-A1 | METHOD FOR PRODUCING NOVEL MICROORGANISMS AND ERGOTHIONEINE | Kureha Corporation (JP) | 2022-11-16 | — | — | EP | disclosed |
| EP-3904499-A4 | STRAIN PRODUCING ERGOTHIONEINE AND SCREENING METHOD THEREOF | Bloomage Biotechnology Corporation Limited (CN) | 2022-10-12 | — | — | EP | disclosed |
| CN-115094101-A | Application of Tremella fuciformis in preparation of ergothioneine | 广东省科学院生物与医学工程研究所 | 2022-09-23 | — | — | CN | disclosed |
| EP-4052704-A1 | COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR SALT THEREOF | Suntory Holdings Limited (JP) | 2022-09-07 | — | — | EP | disclosed |
| US-20220265611-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Consorcio Centro de Investigación Biomédica en Red, M.P. (ES) | 2022-08-25 | — | — | US | disclosed |
| EP-4031095-A1 | SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT THEREOF) AND A PLANT STEM CELL EXTRACT | PM-International AG (LU) | 2022-07-27 | — | — | EP | disclosed |
| US-11376311-B2 | Methods of treating microbial infection and inflammation | Colorado Seminary, Owner and Operator of University of Denver (US) | 2022-07-05 | — | — | US | disclosed |
| CN-113189214-B | Large yellow croaker proliferation and releasing molecular marker and screening method thereof | 宁波大学 | 2022-06-21 | — | — | CN | disclosed |
| US-20220181030-A1 | DETECTION OF RISK OF PRE-ECLAMPSIA IN OBESE PREGNANT WOMEN | Metabolomic Diagnostics Limited (IE) | 2022-06-09 | — | — | US | disclosed |
| EP-4004541-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) | 2022-06-01 | — | — | EP | disclosed |
| EP-4004541-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) | 2022-06-01 | — | — | EP | disclosed |
| CN-114504525-A | Acne-removing cream containing hamamelis virginiana component and preparation method thereof | 新锐(广州)品牌管理有限公司 | 2022-05-17 | — | — | CN | disclosed |
| EP-3816278-A4 | MYOGENIC DIFFERENTIATION-PROMOTING ACTIVITIES OF ERGOTHIONEINE, ASCORBIC ACID 2-GLUCOSIDE, ASCORBIC ACID, AND COMBINATION THEREOF | Nagase & Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3985100-A1 | TRANSFORMED FUNGUS HAVING ENHANCED ERGOTHIONEINE PRODUCTIVITY AND METHOD FOR PRODUCING ERGOTHIONEINE | Kikkoman Corporation (JP) | 2022-04-20 | — | — | EP | disclosed |
| CN-114306124-A | Supermolecule preparation with antioxidant, anti-sugar and anti-blue-light effects and preparation method thereof | 上海忱扬生物科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| JP-2022056858-A | ERGOTHIONEINE-CONTAINING FOOD OR FEED | 国立大学法人広島大学 | 2022-04-11 | — | — | JP | disclosed |
| CN-114269722-A | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2022-04-01 | — | — | CN | disclosed |
| EP-3963048-A1 | METHODS FOR PRODUCTION OF ERGOTHIONEINE | Danmarks Tekniske Universitet (DK) | 2022-03-09 | — | — | EP | disclosed |
| CN-113248442-B | Preparation method of ergothioneine key intermediate | 泰州天鸿生化科技有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-110151619-B | Sunscreen composition containing multiple active substances | 广州盛世名妍健康科技有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| US-20220005605-A1 | A SYSTEM AND METHOD OF GENERATING A MODEL TO DETECT, OR PREDICT THE RISK OF, AN OUTCOME | METABOLOMIC DIAGNOSTICS LEMITED (IE) | 2022-01-06 | — | — | US | disclosed |
| CN-113679635-A | Acanthopanax senticosus extract for cosmetics and application thereof | 楚香(上海)生物科技有限公司 | 2021-11-23 | — | — | CN | disclosed |
| CN-113248442-A | Preparation method of ergothioneine key intermediate | 泰州天鸿生化科技有限公司 | 2021-08-13 | — | — | CN | disclosed |
| WO-2021018774-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL) (ES) | 2021-02-04 | — | — | WO | disclosed |
| US-20210033619-A1 | METHODS OF PREDICTING PRE TERM BIRTH FROM PREECLAMPSIA USING METABOLIC AND PROTEIN BIOMARKERS | Metabolomic Diagnostics Limited (IE) | 2021-02-04 | — | — | US | disclosed |
| WO-2020221795-A1 | METHODS FOR PRODUCTION OF ERGOTHIONEINE | DANMARKS TEKNISKE UNIVERSITET (DK) | 2020-11-05 | — | — | WO | disclosed |
| US-20200261548-A1 | METHODS OF TREATING MICROBIAL INFECTION AND INFLAMMATION | Colorado Seminary, Owner and Operator of University of Denver | 2020-08-20 | — | — | US | disclosed |
| CN-110755328-A | Beautifying, moisturizing and repairing composition and application thereof | 中国林业科学研究院林产化学工业研究所 | 2020-02-07 | — | — | CN | disclosed |
| CN-110478264-A | A kind of cosmetic or skin composition with delay skin aging effect | SHANGHAI COACH TECH CO LTD | 2019-11-22 | — | — | CN | disclosed |
| CN-110037964-A | A kind of cleaning skin pore Essence | 谢鹏 | 2019-07-23 | — | — | CN | disclosed |
| US-10167490-B2 | Ergothioneine production through metabolic engineering | ERGO HEALTH LLC (US) | 2019-01-01 | — | — | US | disclosed |
| US-9753018-B2 | Selenium-containing compound | FISHERIES RESEARCH AGENCY (JP) | 2017-09-05 | — | — | US | disclosed |
| EP-2576778-B1 | TRANSGENIC REPORTER SYSTEM THAT REVEALS EXPRESSION PROFILES AND REGULATION MECHANISMS OF ALTERNATIVE SPLICING IN RODENTS | UNIV KYOTO (JP) | 2017-08-09 | — | — | EP | disclosed |
| US-20160266079-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | FISHERIES RESEARCH AGENCY (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160243011-A1 | Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof | REVLON CONSUMER PRODUCTS CORPORATION | 2016-08-25 | — | — | US | disclosed |
| US-9393231-B2 | Selenium-containing compound | FISHERIES RESEARCH AGENCY (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20160120792-A1 | FORMULATIONS AND METHODS FOR IMPROVING SKIN CONDITIONS | FREELIFE INTERNATIONAL, INC. (US) | 2016-05-05 | — | — | US | disclosed |
| US-9273364-B2 | Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms | KYOTO UNIVERSITY (JP) | 2016-03-01 | — | — | US | disclosed |
| US-20150297569-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | FISHERIES RESEARCH AGENCY (JP) | 2015-10-22 | — | — | US | disclosed |
| US-9109158-B2 | Selenium-containing compounds | FISHERIES RESEARCH AGENCY (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2895159-A2 | FORMULATIONS COMPRISING IDEBENONE, N-ACETYL-S-FARNESYL-L-CYSTEINE AND ERGOTHIONEINE AND USES THEREOF | ELIZABETH ARDEN INC. (US) | 2015-07-22 | — | — | EP | disclosed |
| WO-2014182917-A1 | FORMULATIONS AND METHODS FOR IMPROVING SKIN CONDITIONS | FREELIFE INTERNATIONAL, INC. (US) | 2014-11-13 | — | — | WO | disclosed |
| WO-2014043230-A2 | FORMULATIONS COMPRISING IDEBENONE, N-ACETYL-S-FARNESYL-L-CYSTEINE AND ERGOTHIONEINE AND USES THEREOF | ELIZABETH ARDEN, INC. (US) | 2014-03-20 | — | — | WO | disclosed |
| US-20130137099-A1 | TRANSGENIC REPORTER SYSTEM THAT REVEALS EXPRESSION PROFILES AND REGULATION MECHANISMS OF ALTERNATIVE SPLICING IN MAMMALIAN ORGANISMS | KYOTO UNIVERSITY (JP) | 2013-05-30 | — | — | US | disclosed |
| US-20110178018-A1 | NOVEL SELENIUM-CONTAINING COMPOUNDS | FISHERIES RESEARCH AGENCY (JP) | 2011-07-21 | — | — | US | disclosed |
| US-7767826-B2 | Process for the synthesis of L-(+)-ergothioneine | PHARMATECH INTERNATIONAL, INC. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20090093642-A1 | PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE | PHARMATECH INTERNATIONAL, INC. | 2009-04-09 | — | — | US | disclosed |
| WO-2009045413-A1 | PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE | PHARMATECH INTERNATIONAL, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20080175935-A1 | Method to Treat Skin Conditions with Narcissus Tazetta Bulb Extract | NUSKIN INTERNATIONAL, INC. | 2008-07-24 | — | — | US | disclosed |
| US-20070104810-A1 | Agents for sequestering aging factors and uses thereof | KERN DALE | 2007-05-10 | — | — | US | disclosed |
| EP-1718143-A2 | AGENTS FOR SEQUESTERING SERUM AGING FACTORS AND USES THEREFORE | Nu Skin International, Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| US-20050226947-A1 | Agents for sequestering serum aging factors and uses therefore | NUSKIN INTERNATIONAL, INC. | 2005-10-13 | — | — | US | disclosed |
| WO-2005076924-A2 | AGENTS FOR SEQUESTERING SERUM AGING FACTORS AND USES THEREFORE | NU SKIN INTERNATIONAL, INC. (US) | 2005-08-25 | — | — | WO | disclosed |
| WO-2005076924-A2 | AGENTS FOR SEQUESTERING SERUM AGING FACTORS AND USES THEREFORE | NU SKIN INTERNATIONAL, INC. (US) | 2005-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167490-B2 | Ergothioneine production through metabolic engineering | HNMT, SHMT1, TST | SLC22A4 447/4885POLB 3901/4885ALPL 3279/4885 |
| US-11376311-B2 | Methods of treating microbial infection and inflammation | LPO, ELANE, MPO | SLC22A4 590/4885POLB 3804/4885ALPL 1099/4885 |
| US-20220265611-A1 | ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF | BHMT2, GNMT, BHMT | SLC22A4 157/4885POLB 3203/4885ALPL 1439/4885 |
| US-11957737-B2 | Methods of treating microbial infection and inflammation | LPO, ELANE, MPO | SLC22A4 590/4885POLB 3804/4885ALPL 1099/4885 |
| US-20160243011-A1 | Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof | NQO1, KEAP1, NDUFB10 | SLC22A4 1094/4885POLB 2571/4885ALPL 1567/4885 |
| US-20110178018-A1 | NOVEL SELENIUM-CONTAINING COMPOUNDS | GPX4, GPX1, SELENOI | SLC22A4 341/4885POLB 841/4885ALPL 2374/4885 |
| US-20200261548-A1 | METHODS OF TREATING MICROBIAL INFECTION AND INFLAMMATION | LPO, ELANE, MPO | SLC22A4 590/4885POLB 3804/4885ALPL 1099/4885 |
| US-20090093642-A1 | PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE | TTPA, DTYMK, TST | SLC22A4 2504/4885POLB 1148/4885ALPL 3225/4885 |
| US-20150297569-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | GPX1, GPX4, SELENOI | SLC22A4 643/4885POLB 1337/4885ALPL 2826/4885 |
| US-20220362349-A1 | METHODS OF TREATING MICROBIAL INFECTION AND INFLAMMATION | LPO, ELANE, MPO | SLC22A4 590/4885POLB 3804/4885ALPL 1099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.